The last few months have been filled with changes at the ICSDP, from new team members to a new location.
We are thrilled to announce that Dr. Dan Werb, a globally recognized expert on the impact of drug policies on health and a co-founder of the ICSDP, has been appointed Director and Scientific Board Chair. As research coordinator, Dan has had a strong hand in ensuring the scientific rigour of our work, as well as in identifying those areas of drug policy that require the ICSDP’s involvement.
We are also delighted to welcome Nazlee Maghsoudi to the ICSDP team as our new Knowledge Translation Manager! Nazlee’s experience advocating for drug policy reform at the grassroots, national, and international levels in a number of organizations is an asset to the ICSDP, and will help our work reach stakeholders at all levels. She has already taken research conducted by the ICSDP to the United Nations, where she challenged member states to consider the body of scientific evidence demonstrating that prohibition has been ineffective at protecting youth.
In other news, the ICSDP has relocated from Vancouver to Toronto, and is now based at the Li Ka Shing Knowledge Institute at St. Michael’s Hospital. Partnering with St. Michael’s will enable the ICSDP to continue developing cutting edge, high impact evidence with a dedicated institutional partner in a strong academic environment, in a city that is known as a hotbed for public policy research and experimentation.
Over the next year, the ICSDP will be contributing to the preparations for the upcoming United Nations General Assembly Special Session (UNGASS) on Drugs, the single most important international meeting on drug policy since 1998. In this context, the ICSDP will be providing policymakers and other stakeholders with the best available scientific evidence on drug policy, and we will continue to work towards ensuring that a strong collective scientific voice is heard on the need for evidence-based drug policy reform.
Many other exciting projects are on the horizon for the ICSDP. Over the coming months, we hope that you check back with us often. We thank you for your continued support and look forward to continuing to work towards effective evidence-based drug policies grounded in human rights.